Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 318 participants.
Also called NCT06834490
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 318 participants
- Sponsor
- Registry
-
NCT06834490
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Russia, Uzbekistan
- Registry status
- Completed
Technical summary
Registry record NCT06834490. Randomized; double masking; primary purpose treatment. Start 2019-11-05 (actual); primary completion 2020-12-08 (actual). Results posted on 2025-10-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia
- Acronym
- MEMO
- Condition
- Chronic Cerebral Ischemia
- Intervention (Drug)
- Mexidol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Pharmasoft
Record details
- Record id
cardio:ct-nct06834490- Content hash
30fa6d42cb00620d4b97339bc37d7755891540d052ad3a67b1e1a19022bb3f2a